Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

PGNX

Progenics Pharmaceuticals (PGNX)

Progenics Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PGNX
FechaHoraFuenteTítuloSímboloCompañía
08/02/202211:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
23/06/202015:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202007:29Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202007:11Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202006:55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202006:00Business WireLantheus Completes Merger with ProgenicsNASDAQ:PGNXProgenics Pharmaceuticals Inc
17/06/202016:33PR Newswire (US)Independent Bank Group Set to Join S&P SmallCap 600NASDAQ:PGNXProgenics Pharmaceuticals Inc
16/06/202015:05GlobeNewswire Inc.Progenics Stockholders Approve Merger with LantheusNASDAQ:PGNXProgenics Pharmaceuticals Inc
27/05/202018:53PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.NASDAQ:PGNXProgenics Pharmaceuticals Inc
18/05/202007:30GlobeNewswire Inc.Progenics to Present Results from the Phase 3 CONDOR Trial of PyL™ (18F-DCFPyL) in Prostate Cancer at the American Society ...NASDAQ:PGNXProgenics Pharmaceuticals Inc
14/05/202008:13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
12/05/202015:33Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PGNXProgenics Pharmaceuticals Inc
08/05/202016:14PR Newswire (US)Progenics Class Action: Halper Sadeh LLP Announces Filing Of Shareholder Class Action Lawsuit Against Progenics Pharmaceutica...NASDAQ:PGNXProgenics Pharmaceuticals Inc
07/05/202015:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PGNXProgenics Pharmaceuticals Inc
07/05/202006:30GlobeNewswire Inc.Progenics Pharmaceuticals Announces First Quarter 2020 Financial Results and Business UpdateNASDAQ:PGNXProgenics Pharmaceuticals Inc
23/04/202016:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PGNXProgenics Pharmaceuticals Inc
23/04/202007:30GlobeNewswire Inc.Progenics Pharmaceuticals Sets First Quarter 2020 Financial Results and Business Update Call for May 7NASDAQ:PGNXProgenics Pharmaceuticals Inc
15/04/202014:16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
14/04/202010:17Business WireADDING MULTIMEDIA Velan Capital Agrees to Support Merger of Lantheus and ProgenicsNASDAQ:PGNXProgenics Pharmaceuticals Inc
14/04/202008:00Business WireVelan Capital Agrees to Support Merger of Lantheus and ProgenicsNASDAQ:PGNXProgenics Pharmaceuticals Inc
19/03/202008:06Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
13/03/202015:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PGNXProgenics Pharmaceuticals Inc
13/03/202007:30GlobeNewswire Inc.PROGENICS PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTSNASDAQ:PGNXProgenics Pharmaceuticals Inc
20/02/202010:30Business WireLantheus and Progenics Agree to Amended Transaction TermsNASDAQ:PGNXProgenics Pharmaceuticals Inc
14/02/202012:42Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PGNXProgenics Pharmaceuticals Inc
06/02/202007:30GlobeNewswire Inc.Progenics Pharmaceuticals Announces Presentations at the 2020 American Society of Clinical Oncology Genitourinary Cancers Sym...NASDAQ:PGNXProgenics Pharmaceuticals Inc
21/01/202015:15GlobeNewswire Inc.Progenics Pharmaceuticals Provides Update on Reconstituted Board’s Ongoing Strategic ReviewNASDAQ:PGNXProgenics Pharmaceuticals Inc
16/01/202008:10GlobeNewswire Inc.Progenics Pharmaceuticals Announces Presentation at the 2020 SNMMI Mid-Winter MeetingNASDAQ:PGNXProgenics Pharmaceuticals Inc
23/12/201906:00GlobeNewswire Inc.Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyL™ in Prostate Cancer Achieved Primary EndpointNASDAQ:PGNXProgenics Pharmaceuticals Inc
22/12/201916:00GlobeNewswire Inc.Progenics Pharmaceuticals to Announce and Host a Conference Call to Discuss Top Line Results from Phase 3 CONDOR Trial of PyL...NASDAQ:PGNXProgenics Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PGNX